Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

BACKGROUND: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The stroke recurrence rate is substantial with aspirin, widely used for secondary prevention. The New Approach riVaroxaban Inhibition of Factor Xa in a Global trial versus ASA to prevenT Embolism in Embolic St...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Stroke J
Main Authors: Hart, Robert G, Sharma, Mukul, Mundl, Hardi, Shoamanesh, Ashkan, Kasner, Scott E, Berkowitz, Scott D, Pare, Guillaume, Kirsch, Bodo, Pogue, Janice, Pater, Calin, Peters, Gary, Davalos, Antoni, Lang, Wilfried, Wang, Yongjun, Wang, Yilong, Cunha, Luis, Eckstein, Jens, Tatlisumak, Turgut, Shamalov, Nikolay, Mikulik, Robert, Lavados, Pablo, Hankey, Graeme J, Czlonkowska, Anna, Toni, Danilo, Ameriso, Sebastian F, Gagliardi, Rubens J, Amarenco, Pierre, Bereczki, Daniel, Uchiyama, Shinichiro, Lindgren, Arne, Endres, Matthias, Brouns, Raf, Yoon, Byung-Woo, Ntaios, George, Veltkamp, Roland, Muir, Keith W, Ozturk, Serefnur, Arauz, Antonio, Bornstein, Natan, Bryer, Alan, O’Donnell, Martin J, Weitz, Jeffrey, Peacock, Frank, Themeles, Ellison, Connolly, Stuart J
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6301240/
https://ncbi.nlm.nih.gov/pubmed/31008276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2396987316663049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados